ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG) — Institutional Holders, Q2 2026
8 institutional investment managers reported a AAPG position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $263.5K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
AAPG in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- MORGAN STANLEYAdded · +421 sh+$7.4K
- WELLS FARGO & COMPANYNew · +200 sh+$3.5K
- BlackRockNew · +6 sh+$105.00
- Caitong International Asset Management , LtdNew · +1 sh+$18.00
Biggest sellers
- XY Capital LtdSold out · -13,014 sh-$228.5K
- Point72 Asset Management, L.P.Trimmed · -2,215 sh-$38.9K
- Tower Research Capital (TRC)Sold out · -518 sh-$9.1K
- UBS Group AGTrimmed · -109 sh-$1.9K
- EverSource Wealth AdvisorsTrimmed · -47 sh-$825.00
AAPG 13F holders ranked 1–8 of 8
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P.#1 · 13,841 sh | 13,841 | $243.0K | <0.01% | -13.8% |
| 2 | MORGAN STANLEY#2 · 919 sh | 919 | $16.1K | 0.00% | +84.5% |
| 3 | WELLS FARGO & COMPANY#3 · 200 sh | 200 | $3.5K | 0.00% | New |
| 4 | EverSource Wealth Advisors#4 · 24 sh | 24 | $421.00 | 0.00% | -66.2% |
| 5 | UBS Group AG#5 · 15 sh | 15 | $263.00 | 0.00% | -87.9% |
| 6 | BlackRock#6 · 6 sh | 6 | $105.00 | 0.00% | New |
| 7 | Caitong International Asset Management , Ltd#7 · 1 sh | 1 | $18.00 | 0.00% | New |
| 8 | ROYAL BANK OF CANADA#8 · 6 sh | 6 | $0.00 | 0.00% | 0.0% |
Funds that sold out of AAPG in Q2 2026 (2)
Held AAPG at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| XY Capital Ltd13,014 sh | 13,014 | $310.6K |
| Tower Research Capital (TRC)518 sh | 518 | $12.4K |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.